| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |